References
- Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014–1023.
- Eun HC, Kwon OS, Yeon JH, Shin HS, Kim BY, Ro BI, Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. [Clinical Trial, Phase III Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2010;63(2):252–258.
- Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377–85.
- Olsen EA, Whiting D, Bergfeld W, Miller J, Hordinsky M, Wanser R, A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57(5):767–774.
- Lucky AW, Piacquadio DJ, Ditre CM, Dunlap F, Kantor I, Pandya AG, A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541–553.
- Perry LM Medicinal plant of East and Southeast Asia: attributed properties and uses: The MIT Press, Massachusettes, USA; 1980.
- Zarghi A, Jenabi M, Ebrahimian AJ. HPLC determination of the stability of tretinoin in tretinoin-minoxidil solution. Pharmaceutica Acta Helvetiae 1998;73:163–165.
- Bandaranayake I, Mirmirani P. Hair loss remedies – separating fact from fiction. Cutis. 2004;73(2):107–114.
- Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med. 2002;8(2):143–152.
- Kwon OS, Han JH, Yoo HG, Chung JH, Cho KH, Eun HC, Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG). Phytomedicine. [Clinical Trial In Vitro Research Support, Non-U.S. Gov't]. 2007;14(7–8):551–555.
- Jantan IB, Yassin MSM, Chin CB, Chen LL, Sim NL. Antifungal activity of the essential oils of nine Zingiberaceae species. Pharmaceutical biology. 2003;41:392–397.
- Xuan DN, Thi Bich N, Leclercq PA. Characterization of the leaf oil of Curcuma aeruginosa Roxb. from Vietnam. J Essential Oil Res. 1995;7:657–659.
- Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol. 2008;59(4):547–566.
- Price VH, Menefee E, Strauss PC. Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment. J Am Acad Dermatol. 1999;41(5):717–721.